Position in NVS
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$263,446
+$6,674 QoQ
Shares Held
1,681
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#1,198
of 1,603 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Post Resch Tallon Group Inc. holds $3,297,693 across 8 Drug Manufacturers - General names. NVS ranks #7 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
30,542 | $735,451 | |
| 2 | JNJ |
Johnson & Johnson
|
1,968 | $499,812 | |
| 3 | MRK |
Merck & Co., Inc.
|
3,422 | $439,727 | |
| 4 | ABBV |
AbbVie Inc.
|
1,664 | $418,728 | |
| 5 | AMGN |
Amgen Inc
|
1,044 | $378,053 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,119 | $352,576 | |
| 7 | NVS |
Novartis AG
This page
|
1,681 | $263,446 | |
| 8 | LLY |
ELI LILLY & Co
|
175 | $209,900 |
All Filings in NVS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $263,446 | 1,681 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $256,772 | 1,681 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $232,862 | 1,689 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $213,519 | 1,665 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $201,481 | 1,665 | Shares | Sole | 2025-07-09 | |
| No filing history on record for this holder in this stock. | ||||||